Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 09 Apr 2025

Umbilical cord stem cells therapy against bacterial pneumonia based on zebrafish pneumonia model

in Inflammation Pharmacology

Xueli Chen
Jian Jin
Xia Chen
Yabin Wu
Youjun Guo
Zuoyu Qian
Hui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546193

152 views

Review

Published on 09 Apr 2025

Oxidative stress in vascular surgical diseases: mechanisms, impacts and therapeutic perspectives

in Inflammation Pharmacology

Haosen Xu
Jin Yang
Zhanhui Wei
Shijie Bao
Zhuo Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527684

109 views

Original Research

Accepted on 08 Apr 2025

Tetramethylpyrazine alleviates acute pancreatitis inflammation by inhibiting pyroptosis via the NRF2 pathway

in Inflammation Pharmacology

Huangen Li
Yi Gao
Minglian Huang
Hongling Zhang
Qingqing Wu
Youpei Huang
Xiaotong Ye
Weiwen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557681

Review

Published on 08 Apr 2025

Anti-inflammatory drugs as potential antimicrobial agents: a review

in Inflammation Pharmacology

Onyedika Emmanuel Okpala
Johana Rondevaldova
Ladislav Kokoska

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1557333

420 views

Original Research

Accepted on 07 Apr 2025

S1PR4-dependent effects of Etrasimod on primary human myeloid immune cell activation

in Inflammation Pharmacology

Fiona Sailer
Megan Palmer
Blerina Aliraj
Jan Heering
Andreas Brockmann
Mohammed A F Elewa
Aissa Röhrig
Ewgenij Proschak
Dariusz T Stepniak
Simeon Ramsey

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590816

Original Research

Accepted on 07 Apr 2025

An off-target effect of Class A CpG-oligonucleotides on suppressing the cyclic GMP-AMP synthase signaling in fibroblastic reticular cells Authors

in Inflammation Pharmacology

Preethi Jayakumar
Ting Jiang
Hai Huang
Meihong Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576151

Review

Accepted on 07 Apr 2025

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations

in Inflammation Pharmacology

Yang Chong
Lingli Wang
Fengsong Nie
Zhaoyu Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561112

Review

Published on 07 Apr 2025

Paeoniflorin: a review of its pharmacology, pharmacokinetics and toxicity in diabetes

in Inflammation Pharmacology

Xue Ou
Zhijie Yu
Chuanyu Pan
Xi Zheng
Dandan Li
Zhenzhen Qiao
Xiaoyuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551368

228 views

Review

Published on 07 Apr 2025

Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway

in Inflammation Pharmacology

Jie Cui
Haonan Li
Tianyi Zhang
Fengli Lin
Meiyun Chen
Guimin Zhang
Zhong Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548073

150 views

Original Research

Accepted on 04 Apr 2025

Esmolol Improves Sepsis Outcomes Through Cardiovascular and Immune Modulation

in Inflammation Pharmacology

Da Jing
Li Xiong
Rong Zhang
Hong Fang
Lin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498227

Review

Published on 04 Apr 2025

The emerging role of vascular endothelial cell-mediated angiogenesis in the imbalance of RA synovial microenvironment and its clinical relevance

in Inflammation Pharmacology

Xingxing Huo
Yanhui Peng
Hui Li
Chen Li
Faxue Liao
Chenggui Miao
Yurong Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1481089

148 views

Original Research

Published on 03 Apr 2025

Exploring the mechanism of triptolide inhibiting the motility of fibroblast-like synoviocytes in rheumatoid arthritis via RhoA/Rho-associated kinase axis, based on network pharmacology, molecular docking and molecular dynamics simulations

in Inflammation Pharmacology

Jiacheng Shen
Yuxuan Fang
Nan Xu
Hongyi Chen
Miao Zhu
Dan Li
Zewen Chu
Masataka Sunagawa
Yanqing Liu
Haibo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545514

308 views

Original Research

Published on 03 Apr 2025

Circ_0098181 binds PKM2 to attenuate liver fibrosis

in Inflammation Pharmacology

Yuan-Yuan Luo
Ya-Ping Guan
Hong-Fei Zhan
Chun-Yan Sun
Ling-Yan Cai
Ke-Gong Tao
Yong Lin
Xin Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517250

231 views

Original Research

Published on 02 Apr 2025

Dynamic risk stratification and treatment optimization in sepsis: the role of NLPR

in Inflammation Pharmacology

Qiqi Chen
Ming Zhang
Yuxin Xia
Ya Deng
Yanna Yang
Lili Dai
Hongxia Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572677

241 views

Editorial

Accepted on 01 Apr 2025

Editorial: Targeting Neuroinflammation for Novel Therapeutics in Neurodegenerative Diseases

in Inflammation Pharmacology

Pukar Khanal
Rupesh Chikhale
Jatin Machhi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602495

108 views

Original Research

Accepted on 01 Apr 2025

The immunostimulatory activity of Epimedium flavonoids involves Toll-like receptor 7/8

in Inflammation Pharmacology

Jingyu Wu
Jingwei Jin
Yi Ou
Min Yao
Jiaquan Liu
Hengxing Ran
Zhengrong Wu
Rihui Wu
Li-She Gan
Dongli Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514284